Effect of Shape and Surface Treatment of the Transmucosal Abutments on Peri-implant Health.

NCT ID: NCT05284461

Last Updated: 2022-03-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-05-01

Study Completion Date

2021-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The sample was comprised by 10 patients in which 40 dental implants are placed in an atrophic maxilla. All the implants were connected to 4 types of transepithelial abutment: i.e: parallel anodized abutment(n=10); parallel mechanized abutmen(n=10)t, convergent anodized abutment(n=10); and convergent mechanized abutment (n=10) three months after insertion implants were extracted with the surrounding hard and soft tissues for the histological evaluation of the clinical performance.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Edentulous; Alveolar Process, Atrophy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mechanized parallel abutments

Implants were immediately covered with this type of abutments after insertion. This is the most common procedure. It would be the gold standard

Group Type PLACEBO_COMPARATOR

dental implant with transepithelial abutments manufactured by Galimplant Dental System (Spain)

Intervention Type DEVICE

Dental implants with transepithelial abutments with distinct morphology

Anodized parallel abutments

Implants were immediately covered with this kind of abutments after insertion. Only the surface treatment varies to the gold standard

Group Type EXPERIMENTAL

dental implant with transepithelial abutments manufactured by Galimplant Dental System (Spain)

Intervention Type DEVICE

Dental implants with transepithelial abutments with distinct morphology

Mechanized convergent abutments

Implants were immediately covered with this kind of abutments after insertion. Only the geometry of the emergence profile varies with regards to the gold standard

Group Type EXPERIMENTAL

dental implant with transepithelial abutments manufactured by Galimplant Dental System (Spain)

Intervention Type DEVICE

Dental implants with transepithelial abutments with distinct morphology

Anodized convergent abutments

Implants were immediately covered with this kind of abutments after insertion. Both the surface treatment and the geometry vary with regards to the gold standard

Group Type EXPERIMENTAL

dental implant with transepithelial abutments manufactured by Galimplant Dental System (Spain)

Intervention Type DEVICE

Dental implants with transepithelial abutments with distinct morphology

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

dental implant with transepithelial abutments manufactured by Galimplant Dental System (Spain)

Dental implants with transepithelial abutments with distinct morphology

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* totally edentulous patients in the upper arch and carriers of conventional complete dentures for more than ten years, without temporomandibular disorders

Exclusion Criteria

* evidence of systemic or psychic pathology that contraindicates implant treatment.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Salamanca

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

JAVIER MONTERO

Professor in Prosthodontics

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinica Odontológica de la Universidad de Salamanca

Salamanca, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

USAL_2021_JMONT

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Bone Level Tapered Multi-Center Study
NCT02569671 ACTIVE_NOT_RECRUITING NA